The Value of no Evidence of Disease (<scp>NED</scp>) in Intermediate‐Stage Hepatocellular Carcinoma After <scp>TACE</scp>: A Real‐World Study
Our study highlights the clinical course of NED states and demonstrates its dynamic prognostic significance in patients with intermediate-stage HCC after TACE. The Image-Bio NED is recommended to serve as an important endpoint during the dynamic management of intermediate-stage HCC.
Authors
- Lujun Shen (ORCID: https://orcid.org/0000-0002-7936-0206)
- Letao Lin (ORCID: https://orcid.org/0000-0002-6750-8883)
- Chao An (ORCID: https://orcid.org/0000-0003-4029-2709)
- Shuanggang Chen
- Zhongguo Zhou (ORCID: https://orcid.org/0000-0002-1929-4278)
- Weijun Fan (ORCID: https://orcid.org/0000-0002-8757-647X)
- Gulijiayina Nuerhashi
- Chen Li (ORCID: https://orcid.org/0000-0001-9845-6791)
- Sen Zhang (ORCID: https://orcid.org/0000-0003-2434-8311)
- Fei Cao (ORCID: https://orcid.org/0000-0003-0083-1528)
- Yujia Wang (ORCID: https://orcid.org/0000-0001-9716-1115)
- Yueqian Wu
- Yiquan Jiang
- Qi Zeng (ORCID: https://orcid.org/0009-0008-1496-5731)
- Zhimin Du
Institutions
- Sun Yat-sen University (CN)
- Yangtze University (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Liver International
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1111/liv.70101
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangzhou Municipal Science and Technology Project